You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ground-shifting legal fight brought by patients against the manufacturers of blockbuster drugs for ...
16 hours ago
0
0
A new study examining trends in calls to poison centers across the country for exposures to delta-8 tetrahydrocannabinol (THC), conducted by researchers at the Center for Injury Research and Policy of the Abigail Wexner Research ...
Sep 9, 2024
0
0
COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have saved more than 1.4 million lives in the World Health Organization's (WHO) European region alone ...
Sep 10, 2024
0
0
The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.
Sep 5, 2024
0
0
Anyone who watched Olympic bronze medalist Ilona Maher giving her rugby opponents the stiff arm knows she is tough as nails. Yet she recently posted a video on social media exhaling deeply, clutching her stomach and leaning ...
Sep 9, 2024
0
0
Treatment with BAY 2927088 led to rapid, substantial, and durable responses in patients with heavily pretreated HER2-mutant non-small cell lung cancer (NSCLC), according to research presented at the International Association ...
Sep 9, 2024
0
0
With schools nationwide back in session, millions of children across the United States will clamber up the jungle gyms and hang from the monkey bars that have been a fixture of playgrounds since they were invented in the ...
Sep 9, 2024
0
0
A research team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD). The blood test analyzes 32 proteins that ...
Sep 10, 2024
0
0
The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients with HER2 mutation-positive non-small cell lung cancer, meeting the primary endpoint of the Beamion ...
Sep 9, 2024
0
0
In January 2024, the U.S. Food and Drug Administration (FDA) required labeling information for all currently available CAR T-cell therapies to include a boxed warning advising prescribers and patients of the potential risks ...
11 hours ago
0
0
